Dergiler / Journal of Microbiology and Infectious Diseases / 2022 / Cilt: 12 - Sayı: 01

Comparative Analysis of B.1.617.2 (Delta) Variant of SARS-CoV-2

Sayfa
38–51
Yayın Tarihi
2022-03-15
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

J Microbiol Infect Dis 2022; 12(1):38-51.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:ABSTRACT The emergence of numerous variants of SARS-CoV-2 has caused massive setbacks and prolonged the COVID-19 pandemic.
📊
Temel Bulgular & Veri:One such variant is B.1.617.2, known as the Delta variant, which was first detected in India.
💡
Sonuç & Katkı:J Microbiol Infect Dis 2022; 12(1):38-51.
🔬Tür:Araştırma Makalesi
📍Kapsam:2022 Verileri
⚙️Değişkenler:SARS-CoV-2 · Spike · Mutation

Abstract

ABSTRACT The emergence of numerous variants of SARS-CoV-2 has caused massive setbacks and prolonged the COVID-19 pandemic. Some of the variants are still under investigation, while some have become a reason of grave concern. One such variant is B.1.617.2, known as the Delta variant, which was first detected in India. A comprehensive analysis and comparison of this particular variant have been done to the original Wuhan strain, and the possible reasons behind rapid mutation have also been discussed. A comprehensive literature search was done to summarize the information on the variants of SARS-CoV-2 and the reasons behind their mutation, with a significant focus on the B.1.617.2 variant. Data were collected from various online sources such as PubMed, Google Scholar, MEDLINE, Worldometer, WHO, CDC, and GISAID. In addition, 3D structures of spike proteins were obtained from Protein Data Bank (PDB). The data shows that the spike protein of the B.1.617.2 strain is highly mutated and has accumulated eight amino acid changes. Besides spike protein, changes in non-structural proteins (nsP2, nsP3, nsP4, nsP12, and nsP15), other structural proteins (nucleocapsid and membrane protein), and accessory proteins (ns3, ns7a) have been observed as well. Furthermore, in almost all the variants of SARS-CoV-2, D614G mutation occurs, suggesting its role in increased infectivity and transmission. New variants are continuously emerging on which we have no control. Spike mutations are more favored and essential in the evolution of new variants because it increases the transmissibility and infectivity of the virus. Therefore, to maximally protect public health, knowledge of different variants is essential. J Microbiol Infect Dis 2022; 12(1):38-51.

🔖

Bu Makaleye Atıf Yap

SHAHANSHAH, M. F. H., JAİN, S., SHARMA, B., GREWALL, A., SWAMİ, S. (2022). Comparative Analysis of B.1.617.2 (Delta) Variant of SARS-CoV-2. Journal of Microbiology and Infectious Diseases, Cilt: 12 - Sayı: 01, 38–51. https://ajindex.com/articles/681364

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Kaur SP, Gupta V. COVID-19 Vaccine: A comprehensive status report. Virus Research. 2020;198114. doi:10.1016/j.virusres.2020.198114 2. Sharma B, Shahanshah MF, Gupta S, Gupta V. Recent advances in the diagnosis of COVID-19: A bird’s eye view. Expert Rev Mol Diagn. 2021;21(5):475-491. doi:10.1080/14737159.2021.1874354 3. Worldometer. COVID live update: 168,291,956 cases and 3,493,098 deaths from the Coronavirus. Available: https://www.worldometers.info/coronavirus/. (Accessed on May 25, 2021). 4. WHO Coronavirus (COVID-19) Dashboard. Available: https://covid19.who.int/. (Accessed on May 25, 2021). 5. Wu C, Liu Y, Yang Y, et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B. 2020;10(5):766-788. doi:10.1016/j.apsb.2020.02.008 6. Wu A, Peng Y, Huang B, et al. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. Cell Host Microbe 2020; 27(3):325-328. doi:10.1016/j.chom.2020.02.001 7. Giovanetti M, Benedetti F, Campisi G, et al. Evolution patterns of SARS-CoV-2: Snapshot on its genome variants. Biochem Biophys Res Commun 2021; 538;88-91. doi:10.1016/j.bbrc.2020.10.102 8. Singh A, Gupta V. SARS-CoV-2 therapeutics: how far do we stand from a remedy? Pharmacol Rep 2021;73(3):750-768. doi:10.1007/s43440-020-00204-0 9. Dolan PT, Whitfield ZJ, Andino R. Mechanisms and Concepts in RNA Virus Population Dynamics and Evolution. Annu Rev Virol 2018; 5(1):69-92. doi:10.1146/annurev-virology-101416-041718 10. Sanjuán R, Domingo-Calap P. Mechanisms of viral mutation. Cell Mol Life Sci. 2016; 73(23):4433-4448. doi:10.1007/s00018-016-2299-6 11. SARS-CoV-2 Variant Classifications and Definitions. CDC; 2021. Available: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/variant-surveillance/variant-info.html (Accessed on May 16, 2021.) 12. What Mutations of SARS-CoV-2 are Causing Concern? 2021. Available: https://www.news-medical.net/health/What-Mutations-of-SARS-CoV-2-are-Causing-Concern.aspx. (Accessed on May 16, 2021). 13. Beskrivelse af udvalgte virus varianter. Statens Serum Institut (SSI); 2021. Available: https://covid19.ssi.dk/virusvarianter/virusvariantbeskrivelser. (Accessed on May 16, 2021). 14. Annavajhala MK, Mohri H, Zucker JE, et al. A Novel SARS-CoV-2 Variant of Concern, B.1.526, Identified in New York. medRxiv. February 2021. doi:10.1101/2021.02.23.21252259 15. Pfizer and Moderna vaccines effective against new NYC variant. Science X staff, Me